Table 2 Efficacy in the intention-to-treat population
Variable | ITT population N = 99 |
|---|---|
Response, n (%) | |
Complete response | 4 (4.0) |
Partial response | 56 (56.6) |
Stable disease | 30 (30.3) |
Progressive disease | 5 (5.1) |
Not available | 4 (4.0) |
ORR, % (95% CI) | 60.6 (50.3 to 70.3) |
DCR, % (95% CI) | 90.9 (83.4 to 95.8) |
Progression-free survival | |
Progression event, n (%) | 68 (68.7) |
Months of progression-free survival, median (Q1-Q3) | 10.1 (6.5-14.8) |
Overall survival | |
Death, n (%) | 57 (57.6) |
Months of overall survival, median (Q1-Q3) | 20.8 (11.6-32.8) |